ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 143 filers reported holding ANIKA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,624,000 | +45.6% | 81,047 | +26.4% | 0.01% | +50.0% |
| Q4 2015 | $2,489,000 | +57.0% | 64,111 | +28.7% | 0.00% | +33.3% |
| Q3 2015 | $1,585,000 | +50.4% | 49,807 | +56.1% | 0.00% | +50.0% |
| Q2 2015 | $1,054,000 | +33.4% | 31,900 | +66.3% | 0.00% | +100.0% |
| Q1 2015 | $790,000 | +1.3% | 19,180 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $780,000 | +1268.4% | 19,180 | +1143.0% | 0.00% | – |
| Q3 2014 | $57,000 | -95.6% | 1,543 | -94.5% | 0.00% | -100.0% |
| Q2 2014 | $1,309,000 | +55.3% | 28,244 | +37.6% | 0.00% | +100.0% |
| Q1 2014 | $843,000 | +17.2% | 20,521 | -6.2% | 0.00% | 0.0% |
| Q4 2013 | $719,000 | -11.5% | 21,886 | -35.4% | 0.00% | 0.0% |
| Q3 2013 | $812,000 | +81100.0% | 33,878 | +47615.5% | 0.00% | – |
| Q2 2013 | $1,000 | – | 71 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
| CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
| AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
| Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
| Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
| Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
| DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
| THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
| NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
| Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |